1. Gilead struggles to recruit patients for coronavirus drug clinical trial in China — Sanofi the latest to work on development of coronavirus vaccine — Former Novartis exec pleads guilty to generic price fixing— See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

ELAN merger

Discussion in 'Alkermes' started by Anonymous, Sep 19, 2011 at 2:16 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I used to work for Elan in 2008. Then one day there was a conference call and we were all gone, from the sales rep up to the VPs. A 60 second conference call and our lives changed. Hoepefully this will not happen to any of you. I still know people who never found another job in the industry and were either too long in pharma/biotech to find anything else or too old (late 40s early 50s) to be hired.

    Good luck to you all
     

  2. Anonymous

    Anonymous Guest

    Your post is 100% on. Age discrimination in pharma is horrble. I know plenty of people in their 40-50 who have never found another job in pharma.
     
  3. Anonymous

    Anonymous Guest

    And that was in 2008, there was still a ray of hope back then
     
  4. Anonymous

    Anonymous Guest

    The only drug that Alkermes markets on its own is Vivitrol. All of the other products are made for other companies.

    If you want to go on some anti-Elan rant, go to another page.
     
  5. Anonymous

    Anonymous Guest

    CURSE of donal gaeney!
     
  6. Anonymous

    Anonymous Guest

    Man stop being a punk azz bytch.
     
  7. anonymous

    anonymous Guest

    Yes. Damn that infernal Donal Gaeney!! He took a lock of my hair and some bones from a fried chicken I ate and I haven't been the same since. Curse you Donal Gaeney!!! Curse you.
     
  8. anonymous

    anonymous Guest

    please please please someone buy out ALKS. It is selling at $20 per share and valuation is <3X earnings
     
  9. anonymous

    anonymous Guest

    I think I saw Donal walking a back hallway in the Waltham office. He's still wearing that tall crooked top hat. i'm worried. Really worried. Hoodoo, Youdoo, Voodoo.